CENTRAL PONTINE MYELINOLYSIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION (TWO CASE REPORTS)
https://doi.org/10.15825/1995-1191-2013-1-89-95
Abstract
Central pontine myelinolysis (CPM) is the rare, but extremely severe complication after orthotopic liver trans- plantation. The reason for CPM is currently not precisely defined. However, the rapid correction of hyponatremia is considered as the main etiological factor. In this paper we present two clinical cases of CPM in patients under- went orthotopic liver transplantation. We also discuss the pathophysiology, epidemiology, clinical presentation, treatment options and preventive measures of CPM.
About the Authors
A. M. DzyadzkoM. L. Katin
O. O. Rummo
A. E. Shcherba
E. O. Santotsky
A. F. Minov
M. Y. Gurova
O. A. Chugunova
Y. V. Slobodin
S. M. Zubritsky
L. L. Avdei
References
1. Adams R.D., Victor M., Mancall E.L. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients // AMA Arch. Neurol. Psychiatry. 1959. Vol. 81. P. 154–172.
2. Ardizzone G., Arrigo A., Schellino M.M. et al. Neuro- logical complications of liver cirrhosis and orthotopic liver transplant // Transplant. Proc. 2006. Vol. 38 (3). P. 789–792.
3. Brown W.D. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis // Curr. Opin. Neurol. 2000. Vol. 13. P. 691–697.
4. Cascales Campos P., Ramirez P., Gonzalez R. et al. Cen- tral pontine and extrapontine myelinolysis: a rare and fa- tal complication after liver transplantation // Transplant. Proc. 2011. Vol. 43 (6). P. 2237–2238.
5. Forgacs B., Merhav H.J., Lappin J. et al. Successful conversion to rapamycin for calcineurin inhibitor-relat- ed neurotoxicity following liver transplantation // Trans- plant. Proc. 2005. Vol 37 (4). P. 1912–1914.
6. Fukazawa K., Nishida S., Aguina L. et al. Central pon- tine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation // Ann. Transplant. 2011. Vol. 16 (3). P. 139–142.
7. Graff-Radford J., Fugate J.E., Kaufmann T.J. et al. Clinical and radiologic correlations of central pontine myelinolysis syndrome // Mayo Clin. Proc. 2011. Vol. 86 (11). P. 1063–1067.
8. Harris C.P., Townsend J.J., Baringer J.R. Symptomatic hyponatraemia: can myelinolysis be prevented by treat- ment? // J. Neurol. Neurosurg. Psychiatry 1993. Vol. 56. P. 626–632.
9. Häussinger D. Hepatic encephalopathy // Acta Gastro- enterol. Belg. 2010. Vol. 73 (4). P. 457–464.
10. Kallakatta R.N., Radhakrishnan A., Fayaz R.K. et al. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 pa- tients // J. Neurol. Neurosurg. Psychiatry. 2011. Vol. 82 (3). P. 326–331.
11. Kim B.S., Lee S.G., Hwang S. et al. Neurologic compli- cations in adult living donor liver transplant recipients // Clin. Transplant. 2007. Vol. 21 (4). P. 544–547.
12. Ludwig K.P., Thiesset H.F., Gayowski T.J. et al. Plas- mapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinoly- sis Occurring Post Orthotopic Liver Transplant // Ann. Pharmacother. 2011. Vol. 45 (2). P. e10.
13. Mittal R., Sheftel H., Demssie Y. Management of hypo- natraemia // Br. J. Hosp. Med. (Lond). 2011. Vol. 72 (2). P. M22–25.
14. Newell K.L., Kleinschmidt-DeMasters B.K. Central pon- tine myelinolysis at autopsy; a twelve year retrospective analysis // J. Neurol. Sci. 1996. Vol. 142. P. 1394–1399.
15. Price B.H., Mesulam M.M. Behavioral manifestations of central pontine myelinolysis // Arch. Neurol. 1987. Vol. 44. P. 671–673.
16. Saner F.H., Koeppen S., Meyer M. et al. Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient // Transpl. Int. 2008. Vol. 21 (4). P. 390–391.
17. Soupart A., Ngassa M., Decaux G. Therapeutic relower- ing of the serum sodium in a patient after excessive cor- rection of hyponatremia // Clin. Nephrol. 1999. Vol. 51. P. 383–386.
18. Starzl T.E., Schneck S.A., Mazzoni G. et al. Acute neu- rological complications after liver transplantation with particular reference to intraoperative cerebral air em- bolus // Ann. Surg. 1978. Vol. 187 (3). P. 236–240.
19. Sterns R.H., Silver S., Kleinschmidt-DeMasters B.K. et al. Current perspectives in the management of hypo- natremia: prevention of CPM // Expert Rev. Neurother. 2007. Vol. 7 (12). P. 1791–1797.
20. Stober C.N., Huynh-Do U. Treating hyponatraemia – not an easy task // Ther. Umsch. 2009. Vol. 66 (11). P. 759– 763.
21. Sveinsson O.A., Pálsson R. Central and extrapontine myelinolysis following correction of extreme hypo- natremia. Case report and review of the literature // Laeknabladid. 2008. Vol. 94 (10). P. 665–671.
22. Williams R., Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure // Hepatology. 1994. Vol. 20 (1 Pt. 2). P. S5–10S.
23. Yu J., Zheng S.S., Liang T.B. et al. Possible causes of central pontine myelinolysis after liver transplantation // World J. Gastroenterol. 2004. Vol. 10 (17). P. 2540– 2543.
24. Zein E.F., Karaa S.E., Rollot F. et al. Treatment of cen- tral pontine myelinolysis with thyrotropin-releasing hormone // Presse Med. 2006. Vol. 35 (4 Pt. 1). P. 618– 620.
Review
For citations:
Dzyadzko A.M., Katin M.L., Rummo O.O., Shcherba A.E., Santotsky E.O., Minov A.F., Gurova M.Y., Chugunova O.A., Slobodin Y.V., Zubritsky S.M., Avdei L.L. CENTRAL PONTINE MYELINOLYSIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION (TWO CASE REPORTS). Russian Journal of Transplantology and Artificial Organs. 2013;15(1):89-95. (In Russ.) https://doi.org/10.15825/1995-1191-2013-1-89-95